This disease does not affect the mind but it does affect the motor neurons (the cells in your brain responsible for movement), which is why people suffering from ALS progressively lose control of their muscles, becoming unable to walk, speak, swallow, and—eventually—breathe.
After he was diagnosed, Stephen Heywood and his brother James started the ALS Therapy Development Institute to find a cure for ALS.
Can We Prevent Neurodegenerative Disorders?
But what about prevention? Is there some way to prevent ALS and other neurodegenerative brain disorders, like Parkinson’s, Alzheimer’s, and multiple sclerosis? Is it possible for the brain to heal itself so that, in the event of toxic exposures, it doesn’t get overwhelmed?Toxins Accumulating in the Brain
As Wright explains in a recent article about his work, though these diseases progress at different rates, they have similarities.In all of these relentless and progressive neurodegenerative diseases, misfolded proteins that should not be there glom together in the brain. When these poorly folded protein chains clump together, they can basically start clogging the brain and impairing proper brain function. The brain has a natural system to remove waste, including misfolded proteins, called the glymphatic system.
So David Wright and his team decided to study the glymphatic system in mice that were genetically modified to express a protein associated with ALS: TDP-43. They turned this protein on and off and then used magnetic resonance imaging to analyze the rodents’ brains.
What they found was that genetically modified mice had compromised glymphatic systems. This suggested to the researchers that improving the brain’s glymphatic functioning could be a way to treat ALS.
According to Wright, the glymphatic system is active mostly during non-REM sleep. In addition, he explained, the brain is best able to clear toxins—in rodents anyway—during side-sleeping.
While studies still need to be done in humans, humans and mice are biologically very similar and this research opens up exciting potential prevention and treatment options.
The keys to preventing neurodegenerative diseases may be to avoid toxins in the first place and also support the glymphatic system so that the brain can best clear misfolded proteins.
- Zamani, A., Walker, A.K., Rollo, B. et al. Impaired glymphatic function in the early stages of disease in a TDP-43 mouse model of amyotrophic lateral sclerosis. Transl Neurodegener 11, 17 (2022). https://doi.org/10.1186/s40035-022-00291-4.
- Jessen NA, Munk AS, Lundgaard I, Nedergaard M. The Glymphatic System: A Beginner’s Guide. Neurochem Res. 2015;40(12):2583-2599. doi:10.1007/s11064-015-1581-6.
- Shokri-Kojori, Ehsan & Wang, Gene-Jack & Wiers, Corinde & Demiral, Baris & Guo, Min & Kim, Sung & Lindgren, Elsa & Ramirez, Veronica & Zehra, Amna & Freeman, Clara & Miller, Gregg & Manza, Peter & Srivastava, Tansha & De Santi, Susan & Tomasi, Dardo & Benveniste, Helene & Volkow, Nora. (2018). β-Amyloid accumulation in the human brain after one night of sleep deprivation. Proceedings of the National Academy of Sciences. 115. 10.1073/pnas.1721694115.
- Sun X, Chen W-D and Wang Y-D (2015) β-Amyloid: the key peptide in the pathogenesis of Alzheimer’s disease Front. Pharmacol. 6:221. doi: 10.3389/fphar.2015.00221.
- Lee H, Xie L, Yu M, Kang H, Feng T, Deane R, Logan J, Nedergaard M, Benveniste H. The Effect of Body Posture on Brain Glymphatic Transport. J Neurosci. 2015 Aug 5;35(31):11034-44. doi: 10.1523/JNEUROSCI.1625-15.2015. PMID: 26245965; PMCID: PMC4524974.
- He XF, Liu DX, Zhang Q, Liang FY, Dai GY, Zeng JS, Pei Z, Xu GQ, Lan Y. Voluntary Exercise Promotes Glymphatic Clearance of Amyloid Beta and Reduces the Activation of Astrocytes and Microglia in Aged Mice. Front Mol Neurosci. 2017 May 19;10:144. doi: 10.3389/fnmol.2017.00144. PMID: 28579942; PMCID: PMC5437122.
- Lundgaard I, Wang W, Eberhardt A, Vinitsky HS, Reeves BC, Peng S, Lou N, Hussain R, Nedergaard M. Beneficial effects of low alcohol exposure, but adverse effects of high alcohol intake on glymphatic function. Sci Rep. 2018 Feb 2;8(1):2246. doi: 10.1038/s41598-018-20424-y. PMID: 29396480; PMCID: PMC5797082.